RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Mark R. Gilbert; James Dignam; Minhee Won; Deborah T. Blumenthal; Michael A. Vogelbaum; Kenneth D. Aldape; Howard Colman; Arnab Chakravarti; Robert Jeraj; Terri S. Armstrong; Jeffrey Scott Wefel; Paul D. Brown; Kurt A. Jaeckle; David Schiff; James Norman Atkins; David Brachman; Maria Werner-Wasik; Ritsuko Komaki; Erik P. Sulman; Minesh P. Mehta

doi:10.1200/jco.2013.31.18_suppl.1

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Mark R. Gilbert, James Dignam, Minhee Won, Deborah T. Blumenthal, Michael A. Vogelbaum, Kenneth D. Aldape, Howard Colman, Arnab Chakravarti, Robert Jeraj, Terri S. Armstrong, Jeffrey Scott Wefel, Paul D. Brown, Kurt A. Jaeckle, David Schiff, James Norman Atkins, David Brachman, Maria Werner-Wasik, Ritsuko Komaki, Erik P. Sulman, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	31
DOIs	https://doi.org/10.1200/jco.2013.31.18_suppl.1
State	Published - Jun 20 2013

Disciplines

Physical Therapy
Medicine and Health Sciences

Access to Document

10.1200/jco.2013.31.18_suppl.1License: Unspecified

Cite this

Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., Wefel, J. S., Brown, P. D., Jaeckle, K. A., Schiff, D., Atkins, J. N., Brachman, D., Werner-Wasik, M., Komaki, R., Sulman, E. P., & Mehta, M. P. (2013). RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology, 31. https://doi.org/10.1200/jco.2013.31.18_suppl.1

Gilbert, MR, Dignam, J, Won, M, Blumenthal, DT, Vogelbaum, MA, Aldape, KD, Colman, H, Chakravarti, A, Jeraj, R, Armstrong, TS, Wefel, JS, Brown, PD, Jaeckle, KA, Schiff, D, Atkins, JN, Brachman, D, Werner-Wasik, M, Komaki, R, Sulman, EP & Mehta, MP 2013, 'RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).', Journal of Clinical Oncology, vol. 31. https://doi.org/10.1200/jco.2013.31.18_suppl.1

@article{9dd167ac222b49eb8c572b7b0542db3c,

title = "RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).",

author = "Gilbert, \{Mark R.\} and James Dignam and Minhee Won and Blumenthal, \{Deborah T.\} and Vogelbaum, \{Michael A.\} and Aldape, \{Kenneth D.\} and Howard Colman and Arnab Chakravarti and Robert Jeraj and Armstrong, \{Terri S.\} and Wefel, \{Jeffrey Scott\} and Brown, \{Paul D.\} and Jaeckle, \{Kurt A.\} and David Schiff and Atkins, \{James Norman\} and David Brachman and Maria Werner-Wasik and Ritsuko Komaki and Sulman, \{Erik P.\} and Mehta, \{Minesh P.\}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2013",

month = jun,

day = "20",

doi = "10.1200/jco.2013.31.18\_suppl.1",

language = "American English",

volume = "31",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

AU - Gilbert, Mark R.

AU - Dignam, James

AU - Won, Minhee

AU - Blumenthal, Deborah T.

AU - Vogelbaum, Michael A.

AU - Aldape, Kenneth D.

AU - Colman, Howard

AU - Chakravarti, Arnab

AU - Jeraj, Robert

AU - Armstrong, Terri S.

AU - Wefel, Jeffrey Scott

AU - Brown, Paul D.

AU - Jaeckle, Kurt A.

AU - Schiff, David

AU - Atkins, James Norman

AU - Brachman, David

AU - Werner-Wasik, Maria

AU - Komaki, Ritsuko

AU - Sulman, Erik P.

AU - Mehta, Minesh P.

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2013/6/20

Y1 - 2013/6/20

UR - http://ascopubs.org/doi/abs/10.1200/jco.2013.31.18_suppl.1

U2 - 10.1200/jco.2013.31.18_suppl.1

DO - 10.1200/jco.2013.31.18_suppl.1

M3 - Article

VL - 31

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Disciplines

Access to Document

Other files and links

Cite this